Canada markets close in 5 hours 49 minutes

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.22+0.03 (+0.17%)
As of 10:09AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
726,437
726,437
517,235
484,145
441,755
Cost of Revenue
41,638
41,638
10,166
19,141
20,550
Gross Profit
684,799
684,799
507,069
465,004
421,205
Operating Expenses
Research Development
351,619
351,619
361,575
239,415
319,130
Selling General and Administrative
406,559
406,559
369,090
396,028
388,661
Total Operating Expenses
758,178
758,178
730,665
635,443
707,791
Operating Income or Loss
-73,379
-73,379
-223,596
-170,439
-286,586
Total Other Income/Expenses Net
5,109
5,109
3,542
2,329
-997
Income Before Tax
-51,036
-51,036
-213,444
-167,519
-280,973
Income Tax Expense
10,250
10,250
2,531
351
611
Income from Continuing Operations
-61,286
-61,286
-215,975
-167,870
-281,584
Net Income
-61,286
-61,286
-215,975
-167,870
-281,584
Net Income available to common shareholders
-61,286
-61,286
-215,975
-167,870
-281,584
Basic EPS
-0.91
-0.37
-1.34
-1.05
-1.79
Diluted EPS
-0.91
-0.37
-1.34
-1.05
-1.79
Basic Average Shares
163,114
163,819
161,683
160,493
157,331
Diluted Average Shares
163,114
163,819
161,683
160,493
157,331